STRATA Skin Sciences, Inc. Stock price

Equities

SSKN

US86272A2069

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
0.378 USD -15.04% Intraday chart for STRATA Skin Sciences, Inc. -22.21% -31.29%
Sales 2023 33.36M Sales 2024 * 31.79M Capitalization 13.25M
Net income 2023 -10M Net income 2024 * -7M EV / Sales 2023 0.58 x
Net cash position 2023 * - Net cash position 2024 * - EV / Sales 2024 * 0.42 x
P/E ratio 2023
-1.77 x
P/E ratio 2024 *
-1.8 x
Employees 114
Yield 2023 *
-
Yield 2024 *
-
Free-Float 61.17%
More Fundamentals * Assessed data
Dynamic Chart
1 day-15.04%
1 week-22.21%
Current month-24.55%
1 month-24.78%
3 months-32.98%
6 months-36.36%
Current year-31.29%
More quotes
1 week
0.36
Extreme 0.36
0.51
1 month
0.36
Extreme 0.36
0.60
Current year
0.36
Extreme 0.36
0.65
1 year
0.26
Extreme 0.262
1.15
3 years
0.26
Extreme 0.262
1.95
5 years
0.26
Extreme 0.262
2.99
10 years
0.26
Extreme 0.262
31.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 18-04-09
Director of Finance/CFO 42 21-07-05
Chief Operating Officer - 14-12-31
Members of the board TitleAgeSince
Director/Board Member 64 22-02-13
Chairman 56 18-05-28
Director/Board Member 70 -
More insiders
Date Price Change Volume
24-03-28 0.378 -15.04% 136,664
24-03-27 0.4449 -3.28% 101,046
24-03-26 0.46 -6.12% 29,380
24-03-25 0.49 -1.61% 11,373
24-03-22 0.498 +2.68% 43,832

Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT

More quotes
STRATA Skin Sciences, Inc. is a medical technology company. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions such as psoriasis, vitiligo, and acne. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company's products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The Company's XTRAC excimer laser delivers a targeted therapeutic beam of ultraviolet B (UVB) light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma. Pharos is its excimer laser device that emits concentrated ultraviolet (UV) light and is used as a tool in the treatment of dermatological skin disorders.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.378 USD
Average target price
2.3 USD
Spread / Average Target
+508.47%
Consensus
  1. Stock
  2. Equities
  3. Stock STRATA Skin Sciences, Inc. - Nasdaq